Two Sigma Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

Two Sigma Securities’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.2K	Buy	+10,030	New	+$38.7K	﹤0.01%	1403
2023 Q2	–	Sell	-41,734	Closed	-$439K	–	3071
2023 Q1	$439K	Buy	41,734 +27,560	+194%	+$309K	0.01%	1358
2022 Q4	$176K	Buy	+14,174	New	+$161K	0.01%	1980
2017 Q3	–	Sell	-14,344	Closed	-$227K	–	1064
2017 Q2	$227K	Buy	+14,344	New	+$208K	0.04%	489

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Securities's IRWD Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 10,030 shares worth $42.2K. The stake represents ﹤0.01% of the portfolio and ranks #1403 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in IRWD as recently as Q1 2023.

Two Sigma Securities first reported a position in IRWD in Q2 2017 and has held it in 4 quarters since. The position peaked at $439K in Q1 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Two Sigma Securities held 10,030 shares of Ironwood Pharmaceuticals worth $42.2K as of Q2 2026.
Ironwood Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1403 holding.
Two Sigma Securities first reported a position in Ironwood Pharmaceuticals in Q2 2017 and has held it in 4 quarters since.
Two Sigma Securities's Ironwood Pharmaceuticals position peaked at $439K in Q1 2023.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.